Home › Funds › SMITH CHAS P & ASSOCIATES PA CPAS › AMGN

SMITH CHAS P & ASSOCIATES PA CPAS position in AMGN

AMGEN INC · Health Care

SMITH CHAS P & ASSOCIATES PA CPAS reported holding 117,384 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$50.8M, representing 2.49% of its reported portfolio and ranking #15 among its reported holdings. SMITH CHAS P & ASSOCIATES PA CPAS has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)117.38K sh
Reported value held$50.77M
Portfolio Weight2.49%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SMITH CHAS P & ASSOCIATES PA CPAS's AMGN position evolved

SMITH CHAS P & ASSOCIATES PA CPAS first disclosed a stake in AMGN in Q3 2023 at 105,965 shares (US$28.5M). The position peaked in Q3 2026 at 117,384 shares, worth US$50.8M. Across 13 filings, SMITH CHAS P & ASSOCIATES PA CPAS increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 117,384 shares valued at US$50.8M. Notable position changes include a 41% trim in Q3 2025 (shares rose 16% over the following quarter), a 71% increase in Q4 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 105.97K $28.48M New
Q4 2023 108.84K $31.35M Add
Q1 2024 111.99K $31.84M Add
Q2 2024 113.68K $35.52M Add
Q3 2024 110.88K $35.73M Reduce
Q4 2024 111.55K $29.07M Add
Q1 2025 114.35K $35.63M Add
Q2 2025 116.73K $32.59M Add
Q3 2025 69.27K $19.55M Reduce
Q4 2025 118.29K $38.72M Add
Q1 2026 118.98K $41.86M Add
Q2 2026 117.77K $42.65M Reduce
Q3 2026 117.38K $50.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMGN and 13F data

AMGN (AMGEN INC) is a Health Care company. 30 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), VANGUARD CAPITAL MANAGEMENT LLC (US$14.92B), STATE STREET CORP (US$13.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMGN

All AMGN fund holders →

FAQ

How long has SMITH CHAS P & ASSOCIATES PA CPAS held AMGN?

SMITH CHAS P & ASSOCIATES PA CPAS has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SMITH CHAS P & ASSOCIATES PA CPAS's current position in AMGN?

As of Q3 2026, SMITH CHAS P & ASSOCIATES PA CPAS holds 117.38K shares of AMGN (AMGEN INC), valued at $50.77M, representing 2.49% of its reported portfolio and ranking #15.

Has SMITH CHAS P & ASSOCIATES PA CPAS been buying or selling AMGN?

In the latest 13F filing (Q3 2026), SMITH CHAS P & ASSOCIATES PA CPAS held unchanged its position in AMGN. The position peaked in Q3 2026 at 117.38K shares.

Which other funds hold AMGN?

Other major institutional holders of AMGN include BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.